• A case of cerebrotendinous xanthomatosis with brain and spinal involvement without tendon xanthomas: Identification of a novel mutation of the CYP27A1 gene
• A look behind the scenes: the risk and pathogenesis of primary osteoporosis
• A novel compound heterozygous mutation of WISP3 in progressive pseudorheumatoid dysplasia mimicking juvenile idiopathic arthritis
• A Novel Dipotassium Hydrogen Phosphate Phantom for Calibrating Computed Tomographic Bone Density Measurements in Birds
• A novel large fragment deletion in PLS3 causes rare X-linked early-onset osteoporosis and response to zoledronic acid
• A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis
• A Subtrochanteric Femoral Stress Fracture following Bisphosphonate Treatment in an Adolescent Girl
• Activated FGFR3 suppresses bone regeneration and bone mineralization in an ovariectomized mouse model
• Adiposity Metabolic Consequences for Adolescent Bone Health
• ASSOCIATION OF COL1A1 SP1 AND FOK-I VDR GENETIC POLYMORPHISMS IN YOUNG MALE IDIOPATHIC OSTEOPOROSIS
• Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation
• Back pain and dorsal kyphosis in childhood
• Bisphosphonate treatment of pediatric bone disease
• Bisphosphonates use in children
• Bone densitometry in children and adolescents
• Bone Health in Children with Rheumatic Disorders: Focus on Molecular Mechanisms, Diagnosis, and Management
• Bone health in inflammatory bowel disease
• Bone mineral density and microarchitecture change during skeletal growth in harbor seals (Phoca vitulina) from the German coast
• Bone mineral density in children and adolescents with idiopathic chronic musculoskeletal pain syndromes
• Calvarial doughnut lesions associated with high-turnover osteoporosis presenting in childhood
• Case history of juvenile osteoporosis associated with LRP5 abnormality
• Clinical and genetic characteristics of 29 Chinese patients with X-linked hypophosphatemia
• Clinical Characteristics and Treatment Outcomes of Children with Primary Osteoporosis
• COPB2 loss of function causes a coatopathy with osteoporosis and developmental delay
• Delayed skeletal development and IGF-1 deficiency in a mouse model of lysinuric protein intolerance
• Denosumab in pediatric bone disorders and the role of RANKL blockade: a narrative review
• Diagnostic yield of bone fragility gene panel sequencing in children and young adults referred for idiopathic primary osteoporosis at a single regional reference centre
• Do Bisphosphonates Alleviate Pain in Children? A Systematic Review
• Early identification of a 12-bp tandem duplication in TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK): Clinical characterization and response to bisphosphonate therapy
• Effect of alendronate on the mandible and long bones: an experimental study in vivo
• Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures
• Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescents
• Efficacy and treatment costs of zoledronate versus pamidronate in paediatric osteoporosis
• Evidence of altered matrix composition in iliac crest biopsies from patients with idiopathic juvenile osteoporosis
• Factors affecting bone mineral density in children and adolescents with systemic lupus erythematosus
• Foot and Ankle Conventional Radiography in Juvenile Idiopathic Arthritis: Does It Still Matter?
• Genetic control of bone mass
• Genetics of Osteoporosis in Children
• Germline <em>NUP98</em> Variants in Two Siblings with a Rothmund-Thomson-Like Spectrum: Protein Functional Changes Predicted by Molecular Modeling
• Hajdu Cheney Syndrome due to NOTCH2 defect - First case report from Pakistan and review of literature
• High-molecular-weight Hyaluronan Administration Inhibits Bone Resorption and Promotes Bone Formation in Young-age Osteoporosis Rats
• How does a physical activity programme in elementary school affect fracture risk? A prospective controlled intervention study in Malmo, Sweden
• Hyaline juvenile fibromatosis: clinic, diagnostics, treatment
• Hypercalcemia following discontinuation of denosumab therapy: A systematic review
• Idiopathic juvenile osteoporosis
• Idiopathic juvenile osteoporosis in a child: a four-year follow-up with review of literature
• Idiopathic juvenile osteoporosis--an analysis of the muscle-bone relationship
• Idiopathic Juvenile Osteoporosis: A Case Report
• Idiopathic juvenile osteoporosis: A case report and review of the literature
• Idiopathic juvenile osteoporosis: a cross-sectional single-centre experience with bone histomorphometry and quantitative computed tomography
• Idiopathic Juvenile Osteoporosis: Clinical Experience from a Single Centre and Screening of LRP5 and LRP6 Genes
• Implant degradation of low-alloyed Mg-Zn-Ca in osteoporotic, old and juvenile rats
• Infantile osteopetrosis with superimposed rickets
• Intravenous zoledronic Acid given every 6 months in childhood osteoporosis
• Juvenile Dermatomyositis
• Juvenile osteoporosis
• Juvenile osteoporosis in a 5-year-old girl
• Juvenile osteoporosis with calvarial doughnuts: Progressive high-turnover bone loss responsive to bisphosphonate therapy
• Low bone mineral density in Thai children with systemic lupus erythematosus: prevalence and risk factors
• Massive calcinosis and severe osteoporosis in paediatric-onset overlap syndrome
• Neridronate for transient osteoporosis of the hip in a child
• New Genetic Forms of Childhood-Onset Primary Osteoporosis
• Novel PLS3 variants in X-linked osteoporosis: Exploring bone material properties
• One- and two-stage procedure for revision after failure of anterior cruciate ligament reconstruction
• Osteoporosis - epidemiology and pathogenesis
• Osteoporosis in childhood
• Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5
• Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients' management using bisphosphonates therapy
• Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece
• Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates
• Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment
• Osteoporotic Fractures and Vertebral Body Reshaping in Children With Glucocorticoid-treated Rheumatic Disorders
• Outcomes following intravenous bisphosphonate infusion in pediatric patients: A 7-year retrospective chart review
• Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients
• Pediatric Osteoporosis
• Pediatric osteoporosis: where are we now?
• PiT2 deficiency prevents increase of bone marrow adipose tissue during skeletal maturation but not in OVX-induced osteoporosis
• PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants
• Potential blindness in children of patients with hereditary bone disease
• Primary Osteoporosis
• Primary osteoporosis in children
• Progressive idiopathic juvenile osteoporosis in pregnancy: A case report of two successive pregnancies in the same woman
• PTH(1-34) and zoledronic acid have differing longitudinal effects on juvenile mouse femur strength and morphology
• Radiographic and MR Imaging Findings of the Spine after Bisphosphonate Treatment, in a Child with Idiopathic Juvenile Osteoporosis
• Rare variations in WNT3A and DKK1 may predispose carriers to primary osteoporosis
• Safety and efficacy of probiotic supplementation in 8 types of inflammatory arthritis: A systematic review and meta-analysis of 34 randomized controlled trials
• Sclerostin and Wnt Signaling in Idiopathic Juvenile Osteoporosis Using High-Resolution Confocal Microscopy for Three-Dimensional Analyses
• Secondary forms of osteoporosis. Special features of diagnostics in childhood and adolescence
• Severe bone loss and multiple fractures in SCN8A-related epileptic encephalopathy
• Severe osteoporosis and high level TSH in a child before the diagnosis of acute lymphoblastic leukemia
• Severity of acute phase reaction in children receiving the first dose of zoledronic acid and the impact of the underlying condition: a cross-sectional study
• Sex hormone replacement in Turner syndrome
• Siglec-15-targeting therapy increases bone mass in rats without impairing skeletal growth
• Siglec-15-targeting therapy protects against glucocorticoid-induced osteoporosis of growing skeleton in juvenile rats
• The inhibitory effect of tocilizumab on systemic bone loss and tendon inflammation in a juvenile Collagen-Induced arthritis rat model
• The risk of bisphosphonate-related osteonecrosis of the jaw in children. A case report and literature review
• The Warburg effect in osteoporosis: Cellular signaling and epigenetic regulation of energy metabolic events to targeting the osteocalcin for phenotypic alteration
• Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial
• Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray
• Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density